# BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance)

> **NCT01376102** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 657 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** BONVIVA(ibandronate) injection

## Key facts

- **NCT ID:** NCT01376102
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 657 (ACTUAL)
- **Last updated:** 2014-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01376102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01376102, "BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01376102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*